Applications from the field of Pharma & Biopharma from Agilent Technologies | LabRulez ICPMS

Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation

Guides

| 2010 | Agilent Technologies

GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS

Instrumentation

GC, GC/MSD, HeadSpace, GC/SQ, HPLC, Ion chromatography, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/SQ, ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Pharmaceutical Analysis using FTIR: Compliance with European, US, Indian, and Japanese Pharmacopoeia

Technical notes

| 2022 | Agilent Technologies

FTIR Spectroscopy

Instrumentation

FTIR Spectroscopy

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Spectroscopy Solutions for Pharmaceuticals

Technical notes

| 2016 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Data Integrity Options for GMP Facilities For the Agilent Cary 3500 UV-Vis Spectrophotometer

Others

| 2022 | Agilent Technologies

Software, UV–VIS spectrophotometry

Instrumentation

Software, UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Workflow Breakthroughs That are Improving Data Quality and Efficiency

Others

| 2020 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25)

Applications

| 2020 | Agilent Technologies

UV–VIS spectrophotometry

Instrumentation

UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Rapid Identification of Raw Materials Inside Packaging

Applications

| 2021 | Agilent Technologies

RAMAN Spectroscopy

Instrumentation

RAMAN Spectroscopy

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

Technical notes

| 2021 | Agilent Technologies

Software, UV–VIS spectrophotometry

Instrumentation

Software, UV–VIS spectrophotometry

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Alcohol Levels Determination in Hand Sanitizers by FTIR

Manuals

| 2020 | Agilent Technologies

FTIR Spectroscopy

Instrumentation

FTIR Spectroscopy

Manufacturer

Agilent Technologies

Industries

Energy & Chemicals , Pharma & Biopharma

ICP Expert Software Installation Instructions for 21 CFR Part 11 Environments

Manuals

| 2018 | Agilent Technologies

Software, ICP/OES

Instrumentation

Software, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma from Agilent Technologies | LabRulez ICPMS

Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation

Pharmaceutical Analysis using FTIR: Compliance with European, US, Indian, and Japanese Pharmacopoeia

Spectroscopy Solutions for Pharmaceuticals

Data Integrity Options for GMP Facilities For the Agilent Cary 3500 UV-Vis Spectrophotometer

Workflow Breakthroughs That are Improving Data Quality and Efficiency

Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25)

Rapid Identification of Raw Materials Inside Packaging

Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

Alcohol Levels Determination in Hand Sanitizers by FTIR

ICP Expert Software Installation Instructions for 21 CFR Part 11 Environments

Related content

Scientists continue to push the boundaries of imaging techniques and reveal the mysterious world of molecules

Preventing early-onset colorectal cancers aim of $25 million award

New Research Reveals Pesticide Mixtures Widespread in Environment, Urging Enhanced Regulatory Measures